Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Metadata
Title
In Conclusion: The Promise of Comprehensive Cancer Control
Authors
Susan True
Tom Kean
Patricia A. Nolan
E. Sue Haviland
Karin Hohman
Publication date
01-10-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue Special Issue 1/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0491-3

Other articles of this Special Issue 1/2005

Cancer Causes & Control 1/2005 Go to the issue

OriginalPaper

Collaborating to Conquer Cancer: A Comprehensive Approach to Cancer Control

OriginalPaper

Cancer-related Disparities: Weathering the Perfect Storm Through Comprehensive Cancer Control Approaches

OriginalPaper

Cancer Survivorship: A New Challenge in Comprehensive Cancer Control

OriginalPaper

The Evaluation of Comprehensive Cancer Control Efforts: Useful Techniques and Unique Requirements

Preface

A Collaborative, Comprehensive Approach to Fulfilling the Promise of Cancer Prevention and Control

OriginalPaper

Translating Research into Improved Outcomes in Comprehensive Cancer Control
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits